Comparison of the hybrid capture II assay with the human papillomavirus DNA chip test for the detection of high-grade cervical lesions

International Journal of Gynecological Cancer

Volumn 19, Issue 5, 2009, Pages 924-928

  Kang, Woo Dae ^a   Kim, Cheol Hong ^a   Cho, Moon Kyoung ^a   Kim, Jong Woon ^a   Kim, Yoon Ha ^a   Choi, Ho Sun ^a   Kim, Seok Mo ^a  

^a Chonnam National University   (South Korea)

Author keywords

High grade cervical lesions; HPV DNA chip test; Human papillomavirus; Hybrid capture II assay

Indexed keywords

VIRUS DNA;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; DNA MICROARRAY; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; INFECTION RATE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; WART VIRUS; ANALYTICAL EQUIPMENT; COMPARATIVE STUDY; GENETICS; MIDDLE AGED; PAPILLOMA VIRUS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REAGENT KITS, DIAGNOSTIC; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 69449083514     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a832a2     Document Type: Article

References (17)

1. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) study Group. J Natl Cancer Inst. 1995;87:796-802.
2. Schecht NF, Kulaga S, Robitaille J, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA. 2001;286:3106-3114.
3. Carozzi FM, Confortini M, Cecchini S et al. Triage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessment. Cancer. 2005;105:2-7.
4. Cuzick J, Szarewski A, Terry G, et al. Human papillomavirus testing in primary cervical screening. Lancet. 1995;345:1533-1536.
5. Hubbard RA. Human papillomavirus testing methods. Arch Pathol Lab Med. 2003;127:940-945.
6. Park JY, Lee SM, Yoo CW, et al. Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer. Gynecol Oncol. 2007;107:39-44.
7. Datta NR, Kumar P, Singh S, et al. Does pretreatment human papillomavirus (HPV) titers predict radiation response and survival outcomes in cancer cervix?-VA pilot study. Gynecol Oncol. 2006;103:100-105.
8. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97:1072-1079.
9. Choi YD, Jung WW, Nam JH, et al. Detection of HPV genotypes in cervical lesions by the HPV DNA chip and sequencing. Gynecol Oncol. 2005;98:369-375.
10. Wright TC Jr, Cox JT, Massad LS, et al. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287:2120-2129.
11. Shlay JC, Dunn T, Byers T, et al. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on Papanicolaou smears. Obstet Gynecol. 2000;96:410-416.
12. Farthing A, Masterson P, Mason WP, et al. Human papillomavirus detection by Hybrid Capture and its possible clinical use. J Clin Pathol. 1994;47:649-652.
13. Lorincz AT, Castle PE, Sherman ME, et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet. 2002;360:228-229.
14. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121:621-632.
15. Lungu O, Sun XW, Felix J, et al. Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. JAMA. 1992;267:2493-2496.
16. Kalantari M, Karlsen F, Johansson B, et al. Human papillomavirus findings in relation to cervical intraepithelial neoplasia grade: a study on 476 Stockholm women, using PCR for detection and typing of HPV. Hum Pathol. 1997;28:899-904.
17. Castellsague X, Diaz M, de Sanjose S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 2006;98:303-315.